Search for: "Boehringer Ingelheim Corporation"
Results 41 - 47
of 47
Sorted by Relevance
|
Sort by Date
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
29 Dec 2011, 6:53 am
Happy Christmas/Hanukkah/solstice and Merry New Year to all our readers. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market: (Patent… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
17 Jun 2010, 6:47 am
In its brief, the DOL argues that the district court in that case committed legal error when it concluded that the pharmaceutical sales representatives employed by Novartis Pharmaceutical Corporation (“NPC”) were exempt from the overtime requirements of the FLSA under the outsides sales and administrative exemptions. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
